GPT and metabolic dysfunction-associated steatotic liver disease: The anti-hyperglycemia drug metformin is reported to reduce levels of liver aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in patients with T2DM and NAFLD [168,169,170,171,172,173,174].